Cargando…
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels
Fluorescent ligand technologies have proved to be powerful tools to improve our understanding of ligand‐receptor interactions. Here we have characterized a small focused library of nine fluorescent ligands based on the highly selective β(2)‐adrenoceptor (β(2)AR) antagonist ICI 118,551. The majority...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130569/ https://www.ncbi.nlm.nih.gov/pubmed/34003582 http://dx.doi.org/10.1002/prp2.779 |
_version_ | 1783694554302513152 |
---|---|
author | Goulding, Joëlle Mistry, Sarah J. Soave, Mark Woolard, Jeanette Briddon, Stephen J. White, Carl W. Kellam, Barrie Hill, Stephen J. |
author_facet | Goulding, Joëlle Mistry, Sarah J. Soave, Mark Woolard, Jeanette Briddon, Stephen J. White, Carl W. Kellam, Barrie Hill, Stephen J. |
author_sort | Goulding, Joëlle |
collection | PubMed |
description | Fluorescent ligand technologies have proved to be powerful tools to improve our understanding of ligand‐receptor interactions. Here we have characterized a small focused library of nine fluorescent ligands based on the highly selective β(2)‐adrenoceptor (β(2)AR) antagonist ICI 118,551. The majority of fluorescent ICI 118,551 analogs had good affinity for the β(2)AR (pK(D) >7.0) with good selectivity over the β(1)AR (pK(D) <6.0). The most potent and selective ligands being 8c (ICI 118,551‐Gly‐Ala‐BODIPY‐FL‐X; β(2)AR pK(D) 7.48), 9c (ICI 118,551‐βAla‐βAla‐BODIPY‐FL‐X; β(2)AR pK(D) 7.48), 12a (ICI 118,551‐PEG‐BODIPY‐X‐630/650; β(2)AR pK(D) 7.56), and 12b (ICI 118,551‐PEG‐BODIPY‐FL; β(2)AR pK(D) 7.42). 9a (ICI 118,551‐βAla‐βAla‐BODIPY‐X‐630/650) had the highest affinity at recombinant β(2)ARs (pK(D) 7.57), but also exhibited significant binding affinity to the β(1)AR (pK(D) 6.69). Nevertheless, among the red fluorescent ligands, 9a had the best imaging characteristics in recombinant HEK293 T cells and labeling was mostly confined to the cell surface. In contrast, 12a showed the highest propensity to label intracellular β(2)ARs in HEK293 T cell expressing exogenous β(2)ARs. This suggests that a combination of the polyethylene glycol (PEG) linker and the BODIPY‐X‐630/650 makes this ICI 118,551 derivative particularly susceptible to crossing the cell membrane to access the intracellular β(2)ARs. We have also used these ligands in combination with CRISPR/Cas9 genome‐edited HEK293 T cells to undertake for the first time real‐time ligand binding to native HEK293 T β(2)ARs at low native receptor expression levels. These studies provided quantitative data on ligand‐binding characteristics but also allowed real‐time visualization of the ligand‐binding interactions in genome‐edited cells using NanoBRET luminescence imaging. |
format | Online Article Text |
id | pubmed-8130569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81305692021-05-21 Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels Goulding, Joëlle Mistry, Sarah J. Soave, Mark Woolard, Jeanette Briddon, Stephen J. White, Carl W. Kellam, Barrie Hill, Stephen J. Pharmacol Res Perspect Original Articles Fluorescent ligand technologies have proved to be powerful tools to improve our understanding of ligand‐receptor interactions. Here we have characterized a small focused library of nine fluorescent ligands based on the highly selective β(2)‐adrenoceptor (β(2)AR) antagonist ICI 118,551. The majority of fluorescent ICI 118,551 analogs had good affinity for the β(2)AR (pK(D) >7.0) with good selectivity over the β(1)AR (pK(D) <6.0). The most potent and selective ligands being 8c (ICI 118,551‐Gly‐Ala‐BODIPY‐FL‐X; β(2)AR pK(D) 7.48), 9c (ICI 118,551‐βAla‐βAla‐BODIPY‐FL‐X; β(2)AR pK(D) 7.48), 12a (ICI 118,551‐PEG‐BODIPY‐X‐630/650; β(2)AR pK(D) 7.56), and 12b (ICI 118,551‐PEG‐BODIPY‐FL; β(2)AR pK(D) 7.42). 9a (ICI 118,551‐βAla‐βAla‐BODIPY‐X‐630/650) had the highest affinity at recombinant β(2)ARs (pK(D) 7.57), but also exhibited significant binding affinity to the β(1)AR (pK(D) 6.69). Nevertheless, among the red fluorescent ligands, 9a had the best imaging characteristics in recombinant HEK293 T cells and labeling was mostly confined to the cell surface. In contrast, 12a showed the highest propensity to label intracellular β(2)ARs in HEK293 T cell expressing exogenous β(2)ARs. This suggests that a combination of the polyethylene glycol (PEG) linker and the BODIPY‐X‐630/650 makes this ICI 118,551 derivative particularly susceptible to crossing the cell membrane to access the intracellular β(2)ARs. We have also used these ligands in combination with CRISPR/Cas9 genome‐edited HEK293 T cells to undertake for the first time real‐time ligand binding to native HEK293 T β(2)ARs at low native receptor expression levels. These studies provided quantitative data on ligand‐binding characteristics but also allowed real‐time visualization of the ligand‐binding interactions in genome‐edited cells using NanoBRET luminescence imaging. John Wiley and Sons Inc. 2021-05-18 /pmc/articles/PMC8130569/ /pubmed/34003582 http://dx.doi.org/10.1002/prp2.779 Text en © 2021 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Goulding, Joëlle Mistry, Sarah J. Soave, Mark Woolard, Jeanette Briddon, Stephen J. White, Carl W. Kellam, Barrie Hill, Stephen J. Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels |
title | Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels |
title_full | Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels |
title_fullStr | Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels |
title_full_unstemmed | Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels |
title_short | Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels |
title_sort | subtype selective fluorescent ligands based on ici 118,551 to study the human β2‐adrenoceptor in crispr/cas9 genome‐edited hek293t cells at low expression levels |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130569/ https://www.ncbi.nlm.nih.gov/pubmed/34003582 http://dx.doi.org/10.1002/prp2.779 |
work_keys_str_mv | AT gouldingjoelle subtypeselectivefluorescentligandsbasedonici118551tostudythehumanb2adrenoceptorincrisprcas9genomeeditedhek293tcellsatlowexpressionlevels AT mistrysarahj subtypeselectivefluorescentligandsbasedonici118551tostudythehumanb2adrenoceptorincrisprcas9genomeeditedhek293tcellsatlowexpressionlevels AT soavemark subtypeselectivefluorescentligandsbasedonici118551tostudythehumanb2adrenoceptorincrisprcas9genomeeditedhek293tcellsatlowexpressionlevels AT woolardjeanette subtypeselectivefluorescentligandsbasedonici118551tostudythehumanb2adrenoceptorincrisprcas9genomeeditedhek293tcellsatlowexpressionlevels AT briddonstephenj subtypeselectivefluorescentligandsbasedonici118551tostudythehumanb2adrenoceptorincrisprcas9genomeeditedhek293tcellsatlowexpressionlevels AT whitecarlw subtypeselectivefluorescentligandsbasedonici118551tostudythehumanb2adrenoceptorincrisprcas9genomeeditedhek293tcellsatlowexpressionlevels AT kellambarrie subtypeselectivefluorescentligandsbasedonici118551tostudythehumanb2adrenoceptorincrisprcas9genomeeditedhek293tcellsatlowexpressionlevels AT hillstephenj subtypeselectivefluorescentligandsbasedonici118551tostudythehumanb2adrenoceptorincrisprcas9genomeeditedhek293tcellsatlowexpressionlevels |